Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucose metabolism in patients with psoriasis

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Comparing apples, oranges and atopic dermatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Optimal sunscreen use, during a sun holiday with a very high ultraviolet index, allows vitamin D synthesis without sunburn

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Are demodex mites the best target for rosacea treatments?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Seborrhoeic dermatitis - understood or understudied?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Epidemiological studies strongly suggest that psoriasis predisposes to type 2 diabetes. Several theories have been proposed to explain how these disease entities might be pathophysiologically connected. Objectives: Our primary objective was to elucidate whether clinical data support the notion of common pathophysiological denominators in patients with psoriasis and type 2 diabetes, and thus to delineate the association between the two conditions that has arisen on the basis of epidemiological studies. Methods: We reviewed clinical studies investigating parameters of glucose metabolism in patients with psoriasis. The PubMed and Embase databases were searched for studies investigating glucose metabolism in adult patients with psoriasis as a primary or secondary end point. Studies had to include a relevant control group. Results: Twenty-six clinical studies reporting on insulin resistance, glucose tolerance or insulin secretion were eligible for review. The results were widely conflicting, with less than half of the studies showing results suggestive of defective glucose metabolism in patients with psoriasis. In general, the studies suffered from a lack of information regarding possible confounders and patient characteristics. Furthermore, the research methods varied, and in all but one study they might not have been appropriate to detect early and subtle defects in glucose metabolism. Conclusions: The available literature does not unequivocally support common pathophysiological denominators in psoriasis and type 2 diabetes. Well-designed clinical studies are needed to expose potential diabetogenic defects in the glucose metabolism in patients with psoriasis.

Original languageEnglish
JournalBritish Journal of Dermatology
Volume180
Issue number2
Pages (from-to)264-271
Number of pages8
ISSN0007-0963
DOIs
Publication statusPublished - 1 Feb 2019

Bibliographical note

doi: 10.1111/bjd.17349

ID: 58139009